Alignment Healthcare EVP sells 25,000 shares

Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, sold 25,000 shares of common stock in an open-market transaction at $24.00 per share.

Accepted by SEC EDGAR 07/01/2026 - 04:38 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, sold 25,000 shares of common stock in an open-market transaction at $24.00 per share. The sale was made under a Rule 10b5-1 trading plan adopted on 03/04/2026. After this transaction, he directly holds 1,103,816 shares, so the sale represents a relatively small portion of his overall stake.

Insider Trade Summary 10b5-1

Net Seller: 25,000 shares

Net Sell 1 txn

Insider KONOWIECKI JOSEPH S

Role EVP, Corporate Affairs

Sold 25,000 shs ($600K)

Type	Security	Shares	Price	Value
Sale	Common Stock	25,000	$24.00	$600K

Holdings After Transaction: Common Stock — 1,103,816 shares (Direct)

Footnotes (1)

1. F1. Date of adoption of Rule 10b5-1 plan: 03/04/2026

Key Figures

Shares sold: 25,000 shares Sale price per share: $24.00 per share Shares held after transaction: 1,103,816 shares +3 more

6 metrics

Shares sold 25,000 shares Open-market sale of common stock on 2026-07-01

Sale price per share $24.00 per share Price for the 25,000-share open-market sale

Shares held after transaction 1,103,816 shares Direct ownership following the reported sale

Transaction code S Sale in open market or private transaction

Transaction direction sell Non-derivative common stock transaction

Rule 10b5-1 plan adoption date 03/04/2026 Footnote indicates plan adoption for trading

Key Terms

Rule 10b5-1 plan, open-market sale, Common Stock, Form 4

4 terms

Rule 10b5-1 plan regulatory

"Date of adoption of Rule 10b5-1 plan: 03/04/2026"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alignment Healthcare (ALHC) report on this Form 4?

Alignment Healthcare reported that executive and director Joseph S. Konowiecki sold 25,000 shares of common stock. The sale was an open-market transaction at $24.00 per share and was executed under a pre-established Rule 10b5-1 trading plan.

How many Alignment Healthcare (ALHC) shares did the insider sell and at what price?

Joseph S. Konowiecki sold 25,000 Alignment Healthcare common shares at $24.00 per share. This was a single non-derivative open-market sale, as disclosed in the Form 4 transaction details for the reported date.

How many Alignment Healthcare (ALHC) shares does the insider hold after the sale?

Following the reported transaction, Joseph S. Konowiecki directly holds 1,103,816 shares of Alignment Healthcare common stock. This post-transaction balance shows that he retains a substantial equity position after the 25,000-share sale.

Was the Alignment Healthcare (ALHC) insider sale made under a Rule 10b5-1 trading plan?

Yes. A footnote states the date of adoption of a Rule 10b5-1 plan as 03/04/2026. The disclosed open-market sale of 25,000 shares at $24.00 per share was executed pursuant to this pre-arranged trading plan.

What role does Joseph S. Konowiecki hold at Alignment Healthcare (ALHC)?

Joseph S. Konowiecki serves as a director and as Executive Vice President, Corporate Affairs at Alignment Healthcare. His positions are disclosed in the Form 4, which also reports his recent open-market sale of 25,000 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KONOWIECKI JOSEPH S

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Corporate Affairs

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S(1)		25,000	D	$24	1,103,816	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of adoption of Rule 10b5-1 plan: 03/04/2026

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Joseph S. Konowiecki	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)